This compound is a pharmaceutical intermediate used in the synthesis of the beta-lactamase inhibitor tazobactam. It features a complex polycyclic structure containing triazole, amide, ester, and sulfone functional groups, with multiple stereocenters.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 89789-07-1
Ethyl 2-chloropyrimidine-5-carboxylate
pharmaceutical intermediate
H-Tyr(2-Boc-ea)-OMe
pharmaceutical intermediate
5-Chloro-2-cyanopyridine
pharmaceutical intermediate
4-[4-[(5S)-5-(Aminomethyl)-2-oxo-3-oxazolidinyl]phenyl]-3-morpholinone hydrochloride
pharmaceutical intermediate
benzhydryl (2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
PHGXFQIAGFMIHJ-NWSQWKLXSA-N
C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)OC(C3=CC=CC=C3)C4=CC=CC=C4)CN5C=CN=N5
—